PharmaConseil: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PharmaConseil
Largest movements
- Receivables within one year +€40,703
up €40,703 (+29.8%), from €136,553 to €177,255
of which Other amounts receivable: +€26,275
- Cash -€25,690
down €25,690 (-40.5%), from €63,371 to €37,682
mainly Contributions, distributions and other (-€170,000) and Receivables within one year (-€40,703)
- Tangible fixed assets -€17,604
down €17,604 (-12.5%), from €141,001 to €123,397
of which Plant, machinery and equipment: -€9,186
- Stocks and contracts +€9,929
up €9,929 (+9.1%), from €109,208 to €119,137
- Financial fixed assets +€5,431
up €5,431 (+125%), from €4,358 to €9,789
- Other debts +€168,988
up €168,988 (+840%), from €20,127 to €189,116
- Reserves -€109,535
down €109,535 (-56.8%), from €192,961 to €83,426
of which Tax-exempt reserves: -€115,052
- Provisions -€38,351
down €38,351 (-100%), from €38,351 to €0
- Debts after one year -€20,592
down €20,592 (-26.6%), from €77,270 to €56,679
- Trade debts +€12,212
up €12,212 (+18.3%), from €66,714 to €78,926
- Staff costs +€19,124
up €19,124 (+34.1%), from €56,140 to €75,264
- Gross operating margin -€9,422
down €9,422 (-6.8%), from €138,236 to €128,814
- Financial charges -€2,027
down €2,027 (-19.6%), from €10,355 to €8,328
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €455,604 | €468,687 | +€13,083 | +2.9% |
| Fixed assets | 21/28 | €145,359 | €133,186 | -€12,174 | -8.4% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €141,001 | €123,397 | -€17,604 | -12.5% |
| Plant, machinery and equipment | 23 | €71,104 | €61,918 | -€9,186 | -12.9% |
| Furniture and vehicles | 24 | €31,186 | €24,949 | -€6,237 | -20.0% |
| Other tangible fixed assets | 26 | €38,711 | €36,530 | -€2,181 | -5.6% |
| Assets under construction and advance payments | 27 | €0 | €0 | = | |
| Financial fixed assets | 28 | €4,358 | €9,789 | +€5,431 | +125% |
| Current assets | 29/58 | €310,244 | €335,501 | +€25,256 | +8.1% |
| Stocks and contracts in progress | 3 | €109,208 | €119,137 | +€9,929 | +9.1% |
| Stocks | 30/36 | €109,208 | €119,137 | +€9,929 | +9.1% |
| Amounts receivable within one year | 40/41 | €136,553 | €177,255 | +€40,703 | +29.8% |
| Trade receivables | 40 | €49,835 | €64,263 | +€14,428 | +29.0% |
| Other amounts receivable | 41 | €86,718 | €112,992 | +€26,275 | +30.3% |
| Cash at bank and in hand | 54/58 | €63,371 | €37,682 | -€25,690 | -40.5% |
| Deferred charges and accrued income | 490/1 | €1,113 | €1,427 | +€314 | +28.2% |
| Total equity and liabilities | 10/49 | €455,604 | €468,687 | +€13,083 | +2.9% |
| Equity | 10/15 | €211,561 | €102,026 | -€109,535 | -51.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €192,961 | €83,426 | -€109,535 | -56.8% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Tax-exempt reserves | 132 | €115,052 | €0 | -€115,052 | -100% |
| Distributable reserves | 133 | €76,049 | €81,566 | +€5,517 | +7.3% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Provisions and deferred taxes | 16 | €38,351 | €0 | -€38,351 | -100% |
| Deferred taxes | 168 | €38,351 | €0 | -€38,351 | -100% |
| Amounts payable | 17/49 | €205,692 | €366,661 | +€160,968 | +78.3% |
| Amounts payable after more than one year | 17 | €77,270 | €56,679 | -€20,592 | -26.6% |
| Financial debts | 170/4 | €77,270 | €56,679 | -€20,592 | -26.6% |
| Amounts payable within one year | 42/48 | €127,359 | €309,982 | +€182,623 | +143% |
| Current portion of amounts payable after more than one year | 42 | €20,228 | €20,592 | +€364 | +1.8% |
| Trade debts | 44 | €66,714 | €78,926 | +€12,212 | +18.3% |
| Suppliers | 440/4 | €66,714 | €78,926 | +€12,212 | +18.3% |
| Taxes, remuneration and social security | 45 | €20,289 | €21,349 | +€1,060 | +5.2% |
| Taxes | 450/3 | €8,956 | €6,932 | -€2,024 | -22.6% |
| Remuneration and social security | 454/9 | €11,333 | €14,417 | +€3,084 | +27.2% |
| Other amounts payable | 47/48 | €20,127 | €189,116 | +€168,988 | +840% |
| Accrued charges and deferred income | 492/3 | €1,063 | €0 | -€1,063 | -100% |
| Remuneration, social security and pensions | 62 | €56,140 | €75,264 | +€19,124 | +34.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €19,418 | €20,584 | +€1,165 | +6.0% |
| Other operating charges | 640/8 | €578 | €727 | +€149 | +25.8% |
| Gross operating margin | 9900 | €138,236 | €128,814 | -€9,422 | -6.8% |
| Operating profit (loss) | 9901 | €62,099 | €32,239 | -€29,860 | -48.1% |
| Financial income | 75/76B | €2,011 | €1,404 | -€606 | -30.2% |
| Recurring financial income | 75 | €2,011 | €1,404 | -€606 | -30.2% |
| Financial charges | 65/66B | €10,355 | €8,328 | -€2,027 | -19.6% |
| Recurring financial charges | 65 | €10,355 | €8,328 | -€2,027 | -19.6% |
| Profit (loss) for the period before taxes | 9903 | €53,755 | €25,315 | -€28,440 | -52.9% |
| Transfer from deferred taxes | 780 | €5,985 | €38,351 | +€32,365 | +541% |
| Income taxes | 67/77 | €3,535 | €3,201 | -€334 | -9.4% |
| Profit (loss) for the period | 9904 | €56,206 | €60,465 | +€4,259 | +7.6% |
| Transfer from tax-exempt reserves | 789 | €17,956 | €115,052 | +€97,095 | +541% |
| Profit (loss) for the period to be appropriated | 9905 | €74,162 | €175,517 | +€101,355 | +137% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.